Oncology Drug Pemnat Launched By NATCO

by Medindia Content Team on  November 28, 2006 at 2:32 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Oncology Drug Pemnat Launched By NATCO
Natco Pharma Ltd, based in Hyderabad, India, has announced the launch of a generic version of Pemetrexed a drug used to treat certain types of lung cancer. A very costly preparation, Pemnat is priced at Rs 25,500 a vial. However the imported version of the same medication, costs a whopping Rs 79,000.

This marks the launch of the first ever generic version of Pemetrexed, in the global arena. The drug Pemetrexed was formulated before 1995.The Company is quite sure that this new generic version will not get entangled in any litigation issues whatsoever.

The company, in a news release, has informed that, Pemnat will be invaluable to lung cancer patients in whom curative surgery may not help. It ca be used to treat non-small cell lung cancer and certain types of malignant pleural mesothelioma (cancer affecting lining of lungs).The medicine, is available in 20 ml vials in the market for a single injection. It should be administered after chemotherapy, said the company.

Source: Medindia
MST

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Chemotherapy Chemotherapy Drugs Signature Drug Toxicity Oncology Drug Delivery Systems 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive